Fundraising Fox
Amazentis
Lausanne, CH · 2 known investors
Find your way into Amazentis
Sign up to see every warm intro you have to Amazentis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Amazentis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Amazentis is a Swiss longevity-biotech company that developed Mitopure, a proprietary high-purity form of the postbiotic Urolithin A shown in human trials to support mitochondrial health via mitophagy. It brings the molecule to consumers through its Timeline brand of supplements and skincare, and partners with companies including Nestlé Health Science and L'Oréal.
Investors · 2
In the news
Frequently asked questions
- What does Amazentis do?
- Amazentis is a Swiss longevity-biotech company that developed Mitopure, a proprietary high-purity form of the postbiotic Urolithin A shown in human trials to support mitochondrial health via mitophagy. It brings the molecule to consumers through its Timeline brand of supplements and skincare, and partners with companies including Nestlé Health Science and L'Oréal.
- Who are Amazentis's investors?
- Amazentis's investors include Bold Capital Partners, +ND Capital.
- Where is Amazentis headquartered?
- Amazentis is headquartered in Lausanne, CH.